[
    [
        {
            "time": "",
            "orginal_text": "高管减持排行榜：8股减持额超亿元",
            "features": {
                "keywords": [
                    "高管减持",
                    "减持额超亿元"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全行业"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "高管减持排行榜：8股减持额超亿元",
            "scores": {
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 2,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "非银行金融行业深度报告：创业板存量企业质地不一 改革下券商多业务迎良机",
            "features": {
                "keywords": [
                    "非银行金融",
                    "创业板",
                    "券商",
                    "多业务迎良机"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "非银行金融",
                    "券商"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "非银行金融行业深度报告：创业板存量企业质地不一 改革下券商多业务迎良机",
            "scores": {
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "orginal_text": "爱尔眼科吴士君：注册制是上市公司的新赛道",
            "features": {
                "keywords": [
                    "爱尔眼科",
                    "注册制",
                    "新赛道"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "爱尔眼科吴士君：注册制是上市公司的新赛道",
            "scores": {
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "orginal_text": "生物医药行业周报：第三批带量采购即将开展 仿制药集采进入常态",
            "features": {
                "keywords": [
                    "生物医药",
                    "带量采购",
                    "仿制药",
                    "常态化"
                ],
                "sentiment_score": -0.4,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "仿制药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "生物医药行业周报：第三批带量采购即将开展 仿制药集采进入常态",
            "scores": {
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "orginal_text": "烟台市市场监督管理局：定配眼镜等27批次产品不合格 产品质量问题",
            "features": {
                "keywords": [
                    "烟台市",
                    "市场监管",
                    "定配眼镜",
                    "不合格",
                    "产品质量"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "消费品",
                    "眼镜"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "烟台市市场监督管理局：定配眼镜等27批次产品不合格 产品质量问题",
            "scores": {
                "News_content": "烟台市市场监督管理局：定配眼镜等27批次产品不合格 产品质量问题",
                "Correlation": 3,
                "Sentiment": 3,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        }
    ]
]